Venture Capital Report

Similar documents
Venture Capital Report

Venture Capital Report

Venture Capital Report

Venture Capital Report

Venture Capital Report

VentureSource Europe -- 3Q 2014

Venture Capital Report

Venture Capital Report

VentureSource China -- 3Q 2014

Venture Capital Report

VentureSource China -- 1Q 2014

VentureSource U.S. -- 4Q 2013

Venture Capital Report

Venture Capital Report

AFTER NEARLY 3 YEARS OF STEADY GROWTH, U.S. VENTURE INVESTMENT PULLS BACK 7% IN 1 ST QUARTER TO $6.84 BILLION

Venture Capital Report

Venture Capital Report

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

Venture Capital Industry Overview. Powered By:

Silicon Valley Venture Capital Survey Second Quarter 2018

1h Fenwick. Trends in Terms of U.S. Life Science Venture Financings. First Half fenwick & west llp

2013 venture capital trends summary

VentureSource U.S. -- 3Q 2014

Silicon Valley Venture Capital Survey Third Quarter 2017

Digital Health Funding and M&A

FUNDS DATABASE SCOPE INCLUSION CRITERIA DATA HIGHLIGHTS

VENTURE-BACKED IPO EXIT ACTIVITY MORE THAN DOUBLES IN Q WITH STRONGEST QUARTER FOR BIOTECH OFFERINGS SINCE 2000

German & Berlin Tech: performance on the international stage. 14 November 2018 in partnership with

European Private Equity Buyout Review First Quarter Fabrizio Bensch REUTERS

Trends in Terms of U.S. Life Science Venture Financings. Full Year Fenwick. fenwick & west llp

PitchBook. Bet ter Data. Bet ter Decisions. 4Q 2012 Private Equity. Company Inventory. Report. Sponsored by:

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2010)

CANADIAN PRIVATE EQUITY BUYOUT REVIEW

IVC-MEITAR HIGH-TECH EXITS H1/ 2015 REPORT. IVC-Meitar 2014 Exits Report Prepared by IVC Research Center Ltd.

Israel Venture Capital Investments Report Q3 2017

The percentage of Series A rounds declined significantly, to 12% of all deals.

Medtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year

VENTURE-BACKED IPO EXIT ACTIVITY KEEPS MOMENTUM WITH BEST FULL YEAR FOR NEW LISTINGS SINCE 2007; THIRD CONSECUTIVE QUARTER FOR 20+ OFFERINGS SINCE

Venture-Backed Exit Activity Shows Improved Signs of Life in Q1 2010

CANADIAN PRIVATE EQUITY BUYOUT REVIEW

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner

2Q13. Trends in Terms of Venture Financings in Silicon Valley. Second Quarter fenwick & west llp

Central and Eastern Europe Statistics 2005

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2011)

Overview of Venture Equity

VENTURE CAPITAL INVESTING REACHES HIGHEST LEVEL SINCE Q WITH $13.0 BILLION INVESTED DURING Q2 2014, ACCORDING TO THE MONEYTREE REPORT

3Q13. Trends in Terms of Venture Financings in Silicon Valley. Third Quarter Fenwick. fenwick & west llp

Private Equity Market Update. February 2013

Mary Macdonald November 2005

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile

UK s leadership in European tech accelerates and extends beyond London

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Average M&A Deal Size at Highest Level Since 2004

MassMEDIC Annual Meeting

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GLOBAL PRIVATE EQUITY Report Charts

EY survey of investment in innovative companies in France. First half of 2018

NOT FOR DISTRIBUTION IN THE USA,CANADA, JAPAN OR AUSTRALIA

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile

Investor Presentation. November 2018

Venture Capital And Private Equity: A Practitioner's Manual READ ONLINE

THE INSTITUTIONALIZATION OF THE PRE-IPO EQUITY MARKET

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

4 th Quarter Earnings Conference Call

Media & Entertainment Venture Capital In The US - Industry Market Research Report [Download: PDF] [Digital] By IBISWorld READ ONLINE

Venture Capital MAIN CONCLUSIONS FOR Venture Capital Key Indicators. Fundraising Investment Divestment

Is it morning in European tech? ACCIÓ, Barcelona, 6 July 2017

Silicon Valley Venture Capital Survey Fourth Quarter 2018

5.0% 0.0% -5.0% -10.0% -15.0% 10.0% 5.0% 0.0% -5.0% -10.0% -15.0% 10.0% 5.0% 0.0% -5.0% -10.0% 16.00% 13.00% 10.00% 7.00% 4.

VENUE Market Spotlight PE BUYOUTS. February 2017 Edition

Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Angel Investor Networks The Power of Groups

4 th Quarter Earnings Conference Call

2013 Global venture capital confidence survey results. How confident are investors?

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE

presents THE ANGEL CONNECTION

Moving Ahead. Third-quarter Technology venture capital investment increased 33 percent yearover-year. percent quarter-over-quarter.

Private Equity to us does not solely consist of preparing tailor-made acquisition, financing and exit structures, as well as developing and negotiatin

A report on investment gender diversity in the Nordics

4 th Quarter Earnings Conference Call

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

M&A Update 1H Proven. Focused. Trusted. Accounts Receivable Management Healthcare IT Revenue Cycle Management

Venture capital - An introduction into the nature of venture capital

Life Sciences & Healthcare Venture Summit. Funding Healthcare & IT Media October 27, 2009

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Florida Venture Factbook

Trends in Healthcare Investments and Exits 2018

2 nd Quarter Earnings Conference Call

1 st Quarter Earnings Conference Call

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Raising Capital. Get the Money You Need to Grow Your Business. Third Edition. Andrew J. Sherman

Small Business Investment Companies

Fortis to acquire strategic stake in Parkway Holdings, Singapore

State of Venture Capital in the Southeast Q Executive Summary Pacing vs. 2016*

4 th Quarter Earnings Conference Call

Venture Capital Search Highlights

Transcription:

Venture Capital Report Europe 1Q 2018

The following report presents Dow Jones VentureSource s quarterly findings for European venture capital fundraising, investment, valuation, and liquidity. The included charts and graphs offer a comprehensive view of the trends currently affecting the venture capital market. Highlights for 1Q 2018 include: European venture capital funds dropped during the quarter, both in the number of fund closings and in capital raised. Venture capital investment into European companies showed a moderate decrease in deal flow activity and investment levels. M&As registered fewer transactions than the previous quarter and the aggregate deal amounts were significantly lower. IPO exits for VC-backed companies also declined during the quarter, both in terms of number of listings and capital raised. 2

GROWTH EQUITY Starting this quarter, we are reporting on Growth Equity. VentureSource has always tracked this space, but until now they were excluded from the quarterly statistics. Please note that Growth Deals will be included in the Later Stage category, a subsection of Venture Capital Investment. We define Growth Equity as a minority stake investment in privately owned, mature companies that meet the following criteria: No prior equity investment within the first 3 years of business operations; and A proven business model -- generating revenue or profitable; and No VC-type round series is used by the company to label the transaction; and At least one institutional investor participated in the deal. We recently reviewed our entire database to ensure that all companies and transactions are classified consistent with the above criteria. As a result of this review, we re-characterized thousands of historical deals from VC to Growth, or from Growth to VC. As with our Venture Capital statistics, we exclude companies formed for the sole purpose of acquiring other companies, properties, natural resources, or interests. We also exclude companies formed or owned by private equity firms. 3

EUROPEAN VENTURE CAPITAL FUNDRAISING DROPS IN 1Q 2018 FUNDRAISING Investors poured 1.73 billion into 26 European venture capital funds in 1Q 2018. This represents a 16% decrease in the number of funds and a 29% drop in capital raised compared to last quarter. In comparison to the same quarter last year, capital raised decreased by 22% in 1Q 2018, despite a 37% surge in fund closings. The largest fund closing during the quarter was HV Holtzbrinck Ventures Fund VII, which raised 306 million. 40 35 30 25 20 15 10 1.32 2.03 1.20 European VC Fundraising Based on multiple closings (2015 2018) 1.74 2.89 3.00 1.16 2.15 2.23 2.99 1.60 2.45 1.73 3.50 3.00 2.50 2.00 1.50 1.00 5 0.50 0 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 2Q'16 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 4Q'17 1Q'18 Amount Raised ( B) 1.32 2.03 1.20 1.74 2.89 3.00 1.16 2.15 2.23 2.99 1.60 2.45 1.73 Number of Funds 25 27 19 29 31 26 22 30 19 36 21 31 26 0.00 4

LARGEST EUROPEAN VC FUNDS RAISED IN 1Q 2018 FUNDRAISING Firm Name Fund Name Amount ( M) Location Offering Status Fund Type Fund Category Closing Type HV Holtzbrinck Ventures Adviser GmbH HV Holtzbrinck Ventures Fund VII 306.00 Munich, Germany Closed Multi-stage Venture Capital Venture Capital Final DN Capital Global Venture Capital IV LP 200.00 London, United Kingdom Closed Early-stage Venture Capital Venture Capital Final Edmond de Rothschild Investment Partners BioDiscovery V 175.00 Paris, France Closed Multi-stage Venture Capital Venture Capital Final Ventech SA Ventech Capital V LP 140.00 Paris, France Open Early-stage Venture Capital Venture Capital First Ring Capital Ring Capital fund I 140.00 Paris, France Open Early-stage Venture Capital Venture Capital First 5

INVESTMENT INTO EUROPEAN VENTURE-BACKED COMPANIES FALLS IN 1Q 2018 FINANCING European VC-backed companies garnered 4.36 billion through 656 deals in 1Q 2018, showing a 19% drop in investment and a 17% decrease in the number of financings when compared to the prior quarter. In comparison to the same quarter last year, capital raised came in 4% higher, however, the number of financings fell by 14%. Among round classes, later stage financing rounds trended higher both in terms of number of rounds closed and in capital raised. The most favoured industry section during the quarter was Consumer Services, which attracted 1.25 billion in equity investment. Germany is the top destination for equity financing into European VC-backed companies, attracting 1.24 billion during 1Q 2018. 8.00 7.00 6.00 5.00 4.00 3.00 2.00 1.00 0.00 Equity Financings into Europe-based, VC-backed Companies (2015 2018) 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 2Q'16 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 4Q'17 1Q'18 Amount Raised ( B) 5.53 7.16 4.41 7.09 3.43 5.01 3.50 3.97 4.19 5.29 5.28 5.40 4.36 Number of Deals 652 642 603 743 680 751 681 738 761 716 698 791 656 900 800 700 600 500 400 300 200 100 0 6

EQUITY FINANCINGS INTO EUROPE-BASED, VC-BACKED COMPANIES, BY ROUND CLASS (2015 2018) FINANCING 350 Number of Deals 300 250 200 150 100 50 0 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 2Q'16 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 4Q'17 1Q'18 Seed 47 64 52 62 64 65 63 72 77 88 82 99 80 First 195 186 188 238 194 235 221 210 203 199 171 237 195 Second 79 77 76 96 95 93 93 104 133 105 117 99 78 Later 231 234 214 235 225 249 207 253 235 224 244 289 256 7

EQUITY FINANCINGS INTO EUROPE-BASED, VC-BACKED COMPANIES, BY ROUND CLASS (2015 2018) FINANCING 6,000 Amount Raised ( M) 5,000 4,000 3,000 2,000 1,000 0 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 2Q'16 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 4Q'17 1Q'18 Seed 34 37 30 39 51 51 44 58 73 73 86 90 87 First 433 594 660 546 556 657 558 968 838 862 393 653 784 Second 398 752 463 828 706 483 401 502 678 724 810 803 560 Later 4,521 5,608 3,147 5,106 1,903 3,654 2,390 2,924 2,231 2,593 3,716 3,452 2,834 8

EQUITY FINANCINGS INTO EUROPE-BASED, VC-BACKED COMPANIES (1Q 2015 1Q 2018) FINANCING 2.50 Median Equity Deal Size [ M] 2.00 1.50 1.00 0.50 0.00 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 2Q'16 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 4Q'17 1Q'18 Median Equity Deal Size ( M) 1.57 1.83 1.90 1.86 1.83 1.50 1.79 2.00 2.07 2.00 2.22 1.85 2.03 9

EQUITY FINANCINGS INTO EUROPE-BASED, VC-BACKED COMPANIES, BY INDUSTRY GROUP (1Q 2018) FINANCING During 1Q 2018, 28% of the equity financing raised by European VC-backed companies went into Consumer Services. The sector attracted 1.25 billion through 148 deals. Healthcare was the second most favoured industry sector, raising 979.52 million through 96 deals. This represents 22% of total raised capital and 15% of the total number of deals. Business and Financial Services attracted 978.90 million through 162 deals, or 22% of capital raised and 25% of the total number of deals in the quarter. The last of the four major industry sectors, Information Technology (IT), received 809.34 million in 182 deals, which represents 19% of total equity financing and 28% of total deal activity. 1Q 2018 Industry Breakdown By Number of Deals 1Q 2018 Industry Breakdown By Amount Raised 6% 3% 28% 19% 15% 1% 23% 22% 25% 2% 5% Business and Financial Services Consumer Goods Consumer Services Energy & Utilities Healthcare Industrial Goods & Materials Information Technology Business and Financial Services Consumer Goods Consumer Services Energy & Utilities Healthcare 22% 1% 28% Industrial Goods & Materials Information Technology 10

TOP 5 DEALS INTO EUROPEAN VC-BACKED COMPANIES (1Q 2018) FINANCING Co. Name Location Industry Code Industry Segment Industry Group Brief Description Close Date Round Type Raised ( M) Round Investors (* denotes lead) Auto1 Group GmbH Berlin, Germany Shopping Facilitators Consumer Information Services Consumer Services Provider of a marketplace that connects buyers and sellers of used cars. 14/01/2018 Later Stage 380.00 SoftBank Vision Fund* BioNTech AG Mainz, Germany Biotechnology Therapeutics Biopharmaceuticals Healthcare Developer of individualized therapies for cancer and other diseases. 04/01/2018 First Round 223.93 Struengmann Family Office, Redmile Group LLC*, Janus Henderson Investors, Invus Group, Fidelity Management & Research Co. Maxi Mobility Spain SL (Cabify) Madrid, Spain Transportation Services Travel and Leisure Consumer Services Provider of an on-demand service to book cabs with chauffeurs. 22/01/2018 Later Stage 132.70 Western Technology Investment LLC, TheVentureCity, Rakuten Ventures, Liil Ventures, GAT Investments, Endeavor Capital Management N26 GmbH Berlin, Germany Personal/ Commercial Banking Financial Institutions and Services Business and Financial Services Provider of mobile banking products. 20/03/2018 Later Stage 129.86 Tencent Holdings Ltd.*, Allianz X GmbH* Oxford Nanopore Technologies Ltd. Oxford, United Kingdom Diagnostic Equipment (Not Imaging) Medical Devices and Equipment Healthcare Provider of a nanopore DNA sequencer. 20/03/2018 Later Stage 112.02 Host-Plus Pty Ltd., GIC Private Ltd., CCB International Holdings Ltd. 11

MOST ACTIVE INVESTORS FOR EUROPE-BASED, VC-BACKED COMPANIES (1Q 2018) FINANCING 35 Deals Completed 30 31 25 20 15 10 10 10 9 8 7 7 7 7 7 5 0 12

EQUITY FINANCINGS INTO EUROPE-BASED, VC-BACKED COMPANIES BY COUNTRY (1Q 2018) FINANCING Germany ranked first for equity financing into European VC-backed companies in 1Q 2018, attracting 28% of total raised capital and 13% of the number of deals. The country attracted 1.24 billion via 84 deals, representing an 82% increase in capital and a 4% raise in the number of deals when compared with the previous quarter. The United Kingdom raised 1,06 billion through 175 deals, ranking second in terms of capital raised but first in number of transactions. While France ranked third in capital raised with 722.60 million, it took the second place in number of transactions, with 103 deals closed in 1Q18. Spain came fourth both in terms of capital raised and by number of deals. It garnered 310.85 million through 47 deals. Number of Deals in 1Q 2018 by Country (Top 4) Amount Raised in 1Q 2018 by Country (Top 4) 37% 7% 24% 13% 27% 23% 16% 28% United Kingdom France Germany Spain Rest of Europe Germany United Kingdom 7% 17% 24% 19% France Spain Rest of Europe 13

EUROPE 1Q 2018 VENTURE CAPITAL EXIT ACTIVITY LIQUIDITY There were 43 exits through M&As and IPOs for European VC-backed companies during 1Q 2018, representing a 37% decrease on last quarter s activity. M&As represented the largest portion of the quarter s exits with 38 deals and disclosed deal sums amounting to some 864.26 million. That translates into 31% less deals and 77% less capital than last quarter, as well as 38% less deals and 70% less capital than during 1Q 2017. The quarter s five IPOs raised a total of 54.75 million, representing 12% of exits and 6% of raised capital. Exits for European VC backed Companies (2015 2018) 1Q'18 4Q'17 3Q'17 2Q'17 1Q'17 4Q'16 3Q'16 2Q'16 1Q'16 4Q'15 3Q'15 2Q'15 1Q'15 #0 #10 #20 #30 #40 #50 #60 #70 #80 #90 #100 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 2Q'16 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 4Q'17 1Q'18 IPOs 13 17 8 17 7 11 13 17 10 17 8 13 5 M&As 63 54 64 46 67 66 75 75 61 68 50 55 38 14

TOP 3 M&As IN EUROPE (1Q 2018) LIQUIDITY Company Name Location Brief Description Industry Code Industry Segment Industry Group Close Date Round Type Amount Paid ( M) Acquirer Ticketland Ltd. Moscow, Russia Provider of a retail network and online channels for tickets distribution. Shopping Facilitators Consumer Information Services Consumer Services 12/02/2018 Acquisition 46.14 Mobile TeleSystems OJSC Pharmacy2u Ltd. Leeds, United Kingdom Provider of online and traditional prescription pharmacy services. Specialty Retailers Retailers Consumer Services 26/03/2018 Buyout 44.81 G Square Capital Stardust Media and Communication SAS (Cheerz) Paris, France Provider of a photo printing service for users of social networks. Photography Retailers Consumer Services 09/02/2018 Acquisition 36.00 CEWE Stiftung & Co. KGaA 15

EUROPEAN VC-BACKED IPOs (1Q 2015-1Q 2018) LIQUIDITY European IPO activity decreased drastically this quarter. 5 VC-backed companies went public, raising an aggregate 54.75 million. That is a 62% decrease in the number of IPOs and a 92% drop in capital raised, compared to last quarter. With respect to 1Q 2017, when 10 VC-backed companies went public, IPO activity in 1Q 2018 came in 50% lower. The five VC-backed companies that did go public during this quarter gathered 85% less capital than the 10 companies that had their listing in 1Q 2017. The largest European VC-backed IPO during the quarter was Acacia Pharma Group PLC, which raised 40.00 million at a valuation of 190.51 million for its offering on the Euronext Brussels Stock Exchange. 800.00 700.00 600.00 500.00 400.00 300.00 200.00 100.00 0.00 1Q'15 2Q'15 3Q'15 4Q'15 1Q'16 2Q'16 3Q'16 4Q'16 1Q'17 2Q'17 3Q'17 4Q'17 1Q'18 Raised ( M) through IPO 429.40 576.70 699.69 612.93 155.78 227.64 483.22 202.04 357.82 749.81 218.13 661.72 54.75 Number of IPOs 13 17 8 17 7 11 13 17 10 17 8 13 5 18 16 14 12 10 8 6 4 2 0 16

TOP 3 IPOs IN EUROPE (1Q 2018) LIQUIDITY Company Name Location Brief Description Industry Code Industry Segment Industry Group Close Date Raised through IPO ( M) Exchange: Ticker Acacia Pharma Group PLC United Kingdom Developer of pharmaceutical solutions aimed at providing supportive care for cancer patients. Biotechnology Therapeutics Biopharmaceuticals Healthcare 05/03/2018 40.00 EBR: ACPH Immersive VR Education Ltd. Ireland Provider of educational software utilizing virtual reality (VR). Educational / Training Media and Services Media and Content Consumer Services 12/03/2018 6.72 LON:VRED Agillic ApS Denmark Provider of integrated marketing solutions to communications service providers (CSPs). Communications Software Software Information Technology 22/03/2018 4.97 NASDAQ:AGILC 17

ABOUT US & METHODOLOGY Dow Jones VentureSource helps venture capitalists, corporate development executives, investment bankers and service providers find deal and partnership opportunities, perform comprehensive due diligence and examine trends in venture capital investment, fund-raising and liquidity. It provides accurate, comprehensive data on venture-backed companies including their investors and executives in every region, industry and stage of development throughout the world. The investment figures included in this report cover venture backed companies headquartered in Europe, and are based on aggregate findings of Dow Jones proprietary research for VentureSource. This data was collected through surveys of professional firms, interviews with company executives, and from secondary sources. To be included, companies have to receive financing from a venture capital or private equity firm. Our figures do not include companies that have received funding solely from individual, corporate and/or government investors. The data in this report only accounts for equity funding, not convertible debt deals. Figures contained throughout the report are current at time of editorial but subject to change without notice. No statement herein is to be construed as a recommendation to buy or sell securities, or to provide investment advice. 18

ABOUT DOW JONES Dow Jones is a global provider of news and business information, delivering content to consumers and organizations around the world across multiple formats, including print, digital, mobile and live events. Dow Jones has produced unrivaled quality content for more than 125 years and today has one of the world s largest newsgathering operations globally. It produces leading publications and products including the flagship Wall Street Journal, America s largest newspaper by paid circulation; Factiva, Barron s, MarketWatch, Financial News, DJX, Dow Jones Risk & Compliance, Dow Jones Newswires, and Dow Jones VentureSource. MEDIA CONTACT: Sophie Bent +44 (0) 203 426 1381 sophie.bent@dowjones.com 19